Search results
'General Hospital' star John J York returns to work after 'aggressive' cancer treatment
Fox News via Yahoo News· 6 days ago"General Hospital" star John York is ready to return to the show after undergoing bone marrow...
EHA 2024: Monoclonal antibodies continue to dominate multiple myeloma treatments
Pharmaceutical Technology via Yahoo Finance· 2 days agoMany significant Phase I-III studies targeting haematological malignancies, such as multiple myeloma...
Using MRD Status to Deescalate Multiple Myeloma Therapy
MedPage Today· 4 days agoDiscontinuing maintenance therapy in multiple myeloma based on multimodal measurable residual...
Regeneron touts success with bispecific antibody in multiple myeloma trial
Clinical Trials Arena via Yahoo Finance· 6 days agoRegeneron has released encouraging trial results for its multiple myeloma antibody, linvoseltamab....
Beyond BCMA-Directed CAR T-Cell Therapy
MedPage Today· 3 days agoAlthough survival rates for patients with multiple myeloma are improving, with a 5-year rate of about 60%, many patients relapse after treatment....
Pfizer reports data from Phase II multiple myeloma treatment trial
Clinical Trials Arena via Yahoo Finance· 7 days agoPfizer has announced findings from the Phase II MagnetisMM-3 clinical trial of ELREXFIO...
Ride for Roswell: Thousands unite in fight against cancer
WGRZ-TV Buffalo· 1 day agoEvery year the Ride for Roswell brings a community of people together to celebrate cancer survivors...
‘General Hospital’ Star John J. York to Return to Show Following Cancer Battle
Just Jared· 6 days agoJohn J. York is heading back to General Hospital! The 65-year-old soap star, who was diagnosed with...
'General Hospital's John J. York Emotionally Talks Returning to Soap After Cancer Battle
ET Online via AOL· 6 days agoGeneral Hospital star John J. York became emotional while discussing his battle with cancer and the...
Sylvester Cancer Tip Sheet - June 2024 | Newswise
Newswise· 3 days agoA hematologist endorses FDA approval of a new cancer drug, research shows new use for an older drug, multiple myeloma research may secure FDA approval of a